|1.||Lockwood, Samuel F: 7 articles (10/2006 - 05/2004)|
|2.||Gross, Garrett J: 4 articles (10/2006 - 05/2004)|
|3.||Zsila, Ferenc: 2 articles (10/2006 - 06/2006)|
|4.||Bikádi, Zsolt: 2 articles (10/2006 - 06/2006)|
|5.||Hazai, Eszter: 1 article (10/2006)|
|6.||Jackson, Henry L: 1 article (10/2006)|
|7.||Hazen, Stanley L: 1 article (06/2006)|
|8.||Penn, Marc S: 1 article (06/2006)|
|9.||Lauver, D Adam: 1 article (08/2005)|
|10.||Lucchesi, Benedict R: 1 article (08/2005)|
05/28/2004 - "These results suggest that parenteral Cardax may find utility in those clinical applications where pre-treatment of patients at risk for myocardial infarction is performed."
04/01/2005 - "Previous results from our laboratory have shown that a novel carotenoid derivative (disodium disuccinate astaxanthin; Cardax) produced dose-related reductions in myocardial infarct size (IS) in Sprague-Dawley rats when it was administered at any of three doses (25, 50 and 75 mg/kg, iv) on four consecutive days, followed by the acute infarct size study on day 5. Maximum salvage occurred at the highest dose (75 mg/kg) tested, and was shown as a 56% reduction in IS. "
06/06/2006 - "For the current study, it was hypothesized that oral Cardax administration would inhibit oxidative damage of multiple relevant biological targets in a representative, well-characterized murine peritoneal inflammation model. "
06/06/2006 - "The effects of oral Cardax (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo."
10/01/2006 - "Disodium disuccinate astaxanthin has potent cardioprotective effects in animals, with demonstrated preclinical efficacy in the rat, rabbit, and canine models of experimental infarction. "
01/01/2005 - "Disodium disuccinate astaxanthin (Cardax), DDA) has cardioprotective effects in the rat, rabbit, and canine models of experimental infarction. "
10/15/2006 - "The recently recognized direct interaction of the astaxanthin-based soft-drug Cardax to human 5-LOX with molecular modeling, and the downregulation of both 5-HETE and 5-oxo-EET in vivo in a murine peritonitis model, suggest that other important dietary carotenoids may share this enzyme regulatory feature. "
|1.||succinic acid mono- (4- (18- (4- (3- carboxypropionyloxy)- 2,6,6- trimethyl- 3- oxocyclohex- 1- enyl)- 3,7,12,16- tetramethyloctadeca- 1,3,5,7,9,11,13,15,17- nonaenyl)- 3,5,5- trimethyl- 2- oxocyclohex- 3- enyl) ester
|3.||Arachidonate 5-Lipoxygenase (5 Lipoxygenase)
|6.||bis(p-chlorophenyl)acetic acid (DDA)
|1.||Angioplasty (Angioplasty, Transluminal)
|2.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)